Atea Pharmaceuticals, Inc.
AVIR
$3.17
-$0.04-1.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.43% | -21.34% | -18.87% | -17.41% | -12.73% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 38.30% | 18.45% | -7.86% | -14.98% | -49.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.97% | -21.70% | -19.30% | -18.44% | -13.22% |
|
|
|||||
| Total Current Assets | -20.97% | -21.70% | -19.30% | -18.44% | -13.22% |
| Net Property, Plant & Equipment | -35.10% | -32.11% | -29.59% | -27.41% | -25.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 214.76% | -85.89% | 20.56% | -12.42% | -26.10% |
| Total Assets | -20.44% | -21.90% | -19.26% | -18.47% | -13.34% |
|
|
|||||
| Total Accounts Payable | -65.05% | 4.84% | 1,364.56% | 38.06% | 2,919.57% |
| Total Accrued Expenses | -30.18% | -51.23% | 4.89% | 78.14% | 80.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.46% | 5.26% | 5.33% | 5.41% | 5.34% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -47.36% | -42.54% | 33.33% | 64.73% | 234.20% |
|
|
|||||
| Total Current Liabilities | -47.36% | -42.54% | 33.33% | 64.73% | 234.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -56.12% | -48.72% | -43.05% | -38.55% | -34.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.12% | 10.39% | 10.40% | 10.12% | 9.85% |
| Total Liabilities | -40.65% | -35.13% | 23.12% | 43.22% | 143.91% |
|
|
|||||
| Common Stock & APIC | 6.01% | 6.93% | 6.75% | 6.90% | 6.97% |
| Retained Earnings | -53.86% | -85.98% | -111.06% | -142.47% | -171.65% |
| Treasury Stock & Other | 165.19% | 12.56% | 344.66% | 9.68% | 41.04% |
| Total Common Equity | -18.50% | -20.95% | -21.18% | -20.90% | -18.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.50% | -20.95% | -21.18% | -20.90% | -18.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.50% | -20.95% | -21.18% | -20.90% | -18.41% |
|
|
|||||